In preparation for the upcoming rescan of evidence for this coverage guidance, a draft scope statement has been posted for comment from 7/20/2016 to 8 a.m. on 7/27/2016. See our public comment page for details. The coverage guidance scope reflects the separate planned coverage guidance on Corticosteroid Injections for Low Back Pain. Because of this change, a new coverage guidance will be developed for the remaining percutaneous and minimally invasive interventions. It will be tracked on a separate blog under the name "Low Back Pain: Minimally Invasive and Non-Corticosteroid Percutaneous Interventions."